Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP17 gene promoter allelic variant is not associated with prostate cancer.

Urologic oncology - 1 Jan 2000

Lin Cheng-Chieh, Wu Hsi-Chin, Chen Wen-Chi, Chen Huey-Yi, Tsai Fuu-Jen

Abstract excerpt

Prostate cancer is the most common urological malignancy in Taiwan. The formation of prostate cancer has been reported to be associated with androgen. Two key steps in the sex steroid synthesis are mediated by the enzyme cytochrome p450c17alpha which is encoded in the CYP17 gene. Our aim was to i...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Aged, 80 and over
Share to Cell Differentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Primers

Share to Neoplasm Staging

Share to Polymerase Chain Reaction

Share to Prostatic Neoplasms

Share to Steroid 17-alpha-Hydroxylase

Source

Identifiers

PMID: 12954495
DOI: 10.1016/s1078-1439(02)00276-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-12954495-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP17 gene promoter allelic variant is not associated with prostate cancer.PMID 12954495Read ↗

No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.Semantic proximity Read ↗

Relationship between CYP17 gene polymorphisms and risk of prostate cancer.Semantic proximity Read ↗

Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

Effect of CYP17 and PSA gene polymorphisms on prostate cancer risk and circulating PSA levels in the Slovak population.Semantic proximity Read ↗

Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.Semantic proximity Read ↗

Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans.Semantic proximity Read ↗

Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.Semantic proximity Read ↗

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.